Trial Profile
Study to explore the potential impact of early initiated everolimus on tumor recurrence after liver transplantation in patients with hepatocellular carcinoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 May 2018
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 23 May 2018 New trial record
- 11 May 2018 Results published in the Transplantation